GlassScriptPhysician profile
Brian Keith Adler
NPI 1801810007
$1,836.61
in general payments reported to CMS, 2019-2025
31 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $233 · 2021: $340 · 2022: $278 · 2023: $276 · 2024: $352 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $347.26 | 2019-2024 | Freestyle Libre, Freestyle Libre 3 |
| Amgen INC. | $214.80 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Amarin Pharma, INC. | $132.03 | 2019-2021 | |
| Cvrx, INC. | $109.81 | 2024 | Barostim Neo System |
| Indivior INC. | $109.10 | 2020-2025 | Sublocade |
| Abbvie INC. | $106.03 | 2020-2023 | Qulipta, Ubrelvy, Vraylar |
| Exact Sciences Corporation | $86.81 | 2023-2025 | Cologuard Collection Kit |
| Insulet Corporation | $85.53 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $64.98 | 2022 | |
| Glaxosmithkline, LLC. | $49.78 | 2021-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $45.18 | 2019 | |
| Pfizer INC. | $42.05 | 2021-2022 | |
| Lilly USA, LLC | $38.40 | 2023-2025 | Jardiance |
| Baxter Healthcare | $34.49 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Titan Pharmaceuticals, INC. | $32.52 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $31.66 | 2021-2023 | Farxiga |
| Biohaven Pharmaceutical Holding Company LTD. | $29.96 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $29.18 | 2021 | |
| Inari Medical, INC. | $28.89 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $26.86 | 2023 | |
| Hologic Sales and Service, LLC | $26.56 | 2023 | Aptima, Thinprep 2000 Processor |
| Braeburn INC. | $25.12 | 2025 | Brixadi |
| Daiichi Sankyo INC. | $22.41 | 2024 | Injectafer |
| Horizon Therapeutics Plc | $19.99 | 2020 | |
| Incyte Corporation | $19.73 | 2022 | |
| Aytu Biopharma, INC. | $14.37 | 2020 | |
| Boston Scientific Corporation | $14.11 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.39 | 2023 | |
| Irhythm Technologies, INC. | $13.01 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.53 | 2021 | |
| Allergan, INC. | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.